Assessment of anthracycline-related myocardial adrenergic derangement by [123i]metaiodobenzylguanidine scintigraphy
- 1 January 1995
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 31 (1) , 26-31
- https://doi.org/10.1016/0959-8049(94)00357-b
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Myocardial uptake of 111In monoclonal antimyosin Fab in detecting doxorubicin cardiotoxicity in rats. Morphological and hemodynamic findings.Circulation, 1992
- I-123 MIBG and Serial Radionuclide Angiocardiography in Doxorubicin-related CardiotoxicityClinical Nuclear Medicine, 1992
- Assessment of anthracycline-induced myocardial damage by quantitative indium 111 myosin-specific monoclonal antibody studiesEuropean Journal of Nuclear Medicine and Molecular Imaging, 1991
- Right Ventricle Wall Motion Abnormalities in Patients Treated with ChemotherapyClinical Nuclear Medicine, 1991
- Cardiac morphologic and functional changes induced by epirubicin chemotherapy.Journal of Clinical Oncology, 1989
- Scintigraphic assessment of regional cardiac adrenergic innervation.Circulation, 1989
- Influence of specific activity on myocardial uptake of 123I-mIBG in ratsNuclear Medicine Communications, 1988
- Early Detection of Anthracycline-induced Cardiotoxicity by Stress Radionuclide Cineangiography in Conjunction with Fourier Amplitude and Phase AnalysisClinical Nuclear Medicine, 1985
- Radionuclide angiography and endomyocardial biopsy in the assessment of doxorubicin cardiotoxicityCancer, 1984
- Clinical and morphologic cardiac findings after anthracycline chemotherapyThe American Journal of Cardiology, 1983